Oncolytics Biotech Inc. (ONCY) Social Stream



Oncolytics Biotech Inc. (ONCY): $1.84

-0.01 (-0.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ONCY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

ONCOLYTICS BIOTECH INC (ONCY) Price Targets From Analysts

Use the tables below to see what analysts covering ONCOLYTICS BIOTECH INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 2 $15 $6.72 $10.86 $1.83 493.44%
2022-03-04 1 $15 $6.63 $10.815 $1.83 490.98%
2022-08-18 2 $15 $6.63 $10.815 $1.83 490.98%
2022-11-23 4 $15 $3 $8.21 $1.83 348.63%

The Trend in the Analyst Price Target


Over the past 16 months, ONCY's average price target has gone down $0.8.

Over the past 38 weeks, ONCY's average upside potential has been 654.63%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-05 2 15 6.63 10.815 1.36 695.22%
2022-07-15 2 15 6.63 10.815 0.99 992.42%
2022-08-18 3 15 6.63 10.815 1.24 772.18%
2022-08-18 2 15 6.63 10.815 1.24 772.18%
2022-10-06 4 15 3.00 8.210 1.28 541.41%

ONCY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 2 2 0 0 0 4

The Trend in the Broker Recommendations


Over the past 15 months, ONCY's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how ONCOLYTICS BIOTECH INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 31.7% of that group.
  • ONCOLYTICS BIOTECH INC's upside potential (average analyst target price relative to current price) is higher than 465.27% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ONCOLYTICS BIOTECH INC's average analyst price target is greater than 55.3% of them.
  • ONCY has a lower variance in analysts' estimates than -297.5% of stocks in the small market cap category.

Stocks similar to ONCOLYTICS BIOTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AQST, PRVB, and CRNX.

Is ONCY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 13.7346 seconds.